Tri-County Hematology and Oncology-Massillon — Massillon, Ohio

Tri-County Hematology and Oncology-Massillon is a clinical research site located in Massillon, Ohio, United States 44646.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Tri-County Hematology and Oncology-Massillon has participated in 1 clinical trials.

Therapeutic areas: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.

Sponsors: Blue Note Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Massillon

Browse all research sites in Ohio · View every site in Massillon

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tri-County Hematology and Oncology-Massillon?

Tri-County Hematology and Oncology-Massillon has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tri-County Hematology and Oncology-Massillon conducted?

Tri-County Hematology and Oncology-Massillon has 1 clinical trials on record. Their work covers Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.

Is Tri-County Hematology and Oncology-Massillon accredited by Crixeo Clinical Trials?

Tri-County Hematology and Oncology-Massillon has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tri-County Hematology and Oncology-Massillon?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.